Vulvar NeoplasmsEndometrial NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCarcinoma, EndometrioidNeoplasm StagingBreast NeoplasmsAntineoplastic AgentsNeoplasmsOvarian NeoplasmsCombined Modality TherapyPrognosisLung NeoplasmsCisplatinPancreatic NeoplasmsTreatment OutcomeSurvival AnalysisSurvival RateDisease-Free SurvivalAdenocarcinomaUterine NeoplasmsEndometrial HyperplasiaNeoplasm Recurrence, LocalNeoplasm InvasivenessCyclophosphamideTumor Markers, BiologicalNeoplasm MetastasisDoxorubicinEarly Detection of CancerRisk FactorsCell Line, TumorCarcinomaHysterectomyGene Expression Regulation, NeoplasticFollow-Up StudiesStomach NeoplasmsImmunohistochemistryEndometriumColorectal NeoplasmsTamoxifenCystadenocarcinoma, SerousDrug Resistance, NeoplasmProspective StudiesColonic NeoplasmsNeoplasms, Second PrimaryNeoplasm ProteinsPaclitaxelGenital Neoplasms, FemaleCase-Control StudiesNeoplasms, Multiple PrimaryDrug Administration ScheduleRiskProstatic NeoplasmsEtoposideNeoadjuvant TherapyDNA, NeoplasmDisease ProgressionLiver NeoplasmsReceptors, ProgesteroneAntineoplastic Agents, HormonalReceptors, EstrogenCarcinoma, Non-Small-Cell LungTime FactorsPostmenopauseMice, NudeEstrogensAdenocarcinoma, Clear CellKaplan-Meier EstimateCarcinoma, Squamous CellSkin NeoplasmsTesticular NeoplasmsCarboplatinRadiotherapy, AdjuvantGenetic Predisposition to DiseaseCystadenocarcinoma, PapillaryReverse Transcriptase Polymerase Chain ReactionBone NeoplasmsUterine Cervical NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisRetrospective StudiesOdds RatioMutationRisk AssessmentMethotrexateTaxoidsAge FactorsRNA, MessengerNeoplasm GradingRadiotherapyUrinary Bladder NeoplasmsIncidenceApoptosisAntimetabolites, AntineoplasticAntineoplastic Agents, PhytogenicDeoxycytidineVinblastineCohort StudiesNeoplasms, Cystic, Mucinous, and SerousMultivariate AnalysisAdenocarcinoma, Mucinous